Risk.net

ING takes €5.2bn RWA hit from SA-CCR and last of Trim

Regulatory inflation negates RWA decrease from better loan-book quality

  • LinkedIn  
  • Save this article
  • Print this page  

Regulator-mandated model fixes and the phase-out of own formulas for counterparty risk heaped €5.2 billion ($6.1 billion) onto ING’s risk-weighted assets (RWAs) in the second quarter – a double whammy that offset gains of €4.4 billion from recovering loan quality.

The bank’s credit and counterparty credit (CCR) RWAs rose €1.2 billion to €266.4 billion in the quarter, as a final wave of adjustments from the European Central Bank’s (ECB) Targeted Review of Internal Models (Trim), coupled with a

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email [email protected]

To continue reading...

More on Risk Quantum

Derivatives

Most read on Risk.net

  1. Overhyped green status is no longer a risk-free sales tool
  2. 9/11: the colleagues we lost, and the years that followed
  3. OTC derivatives clearing: no turning back
  4. Axes that matter: PCA with a difference
  5. Insurers’ favourite credit rating becomes more expensive

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: